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Enzymes, being remarkable catalysts, are capable of accepting a wide range of complex molecules as substrates 
and catalyze a variety of reactions with a high degree of chemo-, stereo- and regioselectivity in most of the 
reactions. Biocatalysis can be used in both simple and complex chemical transformations without the need for 
tedious protection and deprotection chemistry that is very common in traditional organic synthesis. This current 
review highlights the applicability of one class of biocatalysts viz. ‘‘lipases’’ in synthetic transformations, the 
resolution of pharmaceutically important small molecules including polyphenols, amides, nucleosides and their 
precursors, the development of macromolecular systems (and their applications as drug/gene carriers), flame 
retardants, polymeric antioxidants and nanocrystalline solar cells, etc. 
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1. Introduction 
 
Enzymes are catalysts evolved by nature to sustain biochemical 
reactions in a living cell. Metabolic pathways and cell growth require 
highly diverse reactions that are catalysed by a wide variety of 
natural enzymes. As a consequence, enzymes have evolved as highly 
specialised catalysts for diﬀ erent types of chemical transformations. 
However, the synthetic potential of enzymes was unknown until 
1897, when Eduard Buchner’s work proved that enzymes do not 
require the environment of a living cell to be active. This discovery 
led to the application of enzymes in various fields, one being the 
production of chemicals via biotransformations. In the 1980s the 
scope of biocatalysis was expanded for new applications in synthetic 
chemistry by the observation that enzymes are active in organic 
solvents containing little or no water.1,2 
 
Among the various classes of enzymes known, lipases (hydrolytic 
enzymes) have attracted immense interest in recent years. Lipases 
(EC 3.1.1.3) are ubiquitous enzymes found in all types of living 
organisms from fungi and bacteria to plants and animals. Lipases 
exert their natural function towards the hydrolysis/synthesis of 
carboxylic ester bonds of long-chain triacylglycerols. Beside their 
role in lipid metabolism, lipases are widely used in biotechnology as 
additives in detergents, as food ingredients, as pitch control in the 
pulp and paper industry, and in biopolymers and biodiesel 
production, etc.3 The properties of lipases, such as their stability in 
organic 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
solvents, catalytic activity without cofactors, broad substrate 
specificity, and high reaction chemo-, regio- and stereo-selectivity 
make them the most versatile class of enzymes in synthetic organic 
chemistry.4,5 Ongoing eﬀ orts from our research laboratories, over 
the last three decades, involving lipase-mediated biocatalysis have 
proved to be exceedingly useful in developing highly selective and 
‘greener processes’ for pharmaceutical, fine and specialty chemical 
industries (Fig. 1).6 We have explored a number of lipases to 
synthesise enantiomerically pure pharmaceutical key intermediates  
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and macromolecular architectures with an aim towards broad and 
diverse applications as summarized in this review. 
 
2. Biocatalytic approach to 
small molecules 
 
The synthesis of medicinally significant low molecular weight 
scaﬀ olds which are either naturally occurring or inspired by nature, 
involving methodologies to achieve the desired target 
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molecule in an eﬃcient and cost eﬀ ective manner is of prime 
concern for chemists.7 Though chemocatalysis and biocatalysis 
continue to be active areas of academic research and business 
investment,8 the goal of biocatalysis is to steer the reaction eﬃciency 
in comparison to the earlier reported approaches to achieve low 
molecular weight scaﬀ olds. Our eﬀ orts led to the development of a 
toolbox of facile chemoenzymatic approaches for the synthesis of 
targeted small molecules of interest using lipases. The details of this 
approach are discussed below. 
 
2.1. Polyphenolics 
 
Polyphenols are known to be beneficial in a number of diseases 
including cardiovascular or neurodegenerative diseases, osteo-
porosis and cancer.9 Suitably substituted polyhydric phenols are also 
used as starting materials for the synthesis of diﬀ erent classes of 
natural polyphenolics viz. chalcones, flavones, flava-nones, 
isoflavonoids, coumarins, xanthones, and catechins, etc. Selective 
protection and deprotection steps are often required to achieve the 
total synthesis of these compounds, which are rather diﬃcult. 
Moreover they increase the number of steps and decrease the net 
yields thus making the overall synthesis quite cumbersome. It was 
therefore envisioned to employ enzymes when carrying out selective 
transformations and thus avoiding the cumbersome 
protection/deprotection synthetic steps to achieve the desired 
intermediates. Over the years, we have estab-lished the use of lipases 
from porcine pancreas (PPL), Candida rugosa (CRL), Candida 
antarctica (CAL), Candida cylindracea (CCL), Aspergillus terreus 
(ATL), Aspergillus carneus (ACL), and from 
 
Fusarium and Pseudomonas species when carrying out selective 
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transformations on various peracetylated phenolic compounds 
representing various classes of natural products e.g. flavones, 
flavanones, coumarins, ketones, chromanones, diphenyl ethenes, 
chalcones, catechins, etc. and their intermediates (Fig. 2).10–19 
Selective deacetylations were studied on these substrates and it 
was observed that while using porcine pancreatic lipase (PPL), 
selective deacetylation occurred at the para- and meta-positions with 
reference to the nuclear carbonyl group, in comparison to that at the 
ortho-acetoxy group. These results were found to be important and 
interesting as an ortho-acetoxy moiety would preferentially undergo 
deacetylation under chemical conditions due to chelation of the 
resulting hydroxyl group with the carbonyl group. We proposed that 
the selective transformation occurs via the formation of a dynamic 
Schiﬀ ’s base enzyme–substrate complex between the nuclear 
carbonyl group of the substrate and the amino group of lysine of the 
enzyme, which is present in the active site of PPL. To confirm this 
hypothesis of enzymatic deacylation, a study was conducted with a 
number of variously substituted acetoxy aromatic amides and 
peracetates.20,21 It was concluded that this strategy of acetyla-tion 
can also be employed in the enantiomeric resolution of racemic 
ketones,22 which are important precursors in the synthesis of 
biologically active chromones, amides and isoflavanones.23–28 
 
 
2.2. Biocatalytic reactions in nucleoside chemistry 
 
Nucleosides are fundamental building blocks of biological systems 
and show a wide range of biological activities. They are sequentially 
phosphorylated by kinases into their mono-, di- and triphosphates 
and the resultant nucleotides are processed 
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Fig. 1 Schematic presentation of the lipase catalysed formation of small and polymeric materials and their applications. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2 Lipase catalysed selective deacetylation reactions. 
 
 
into nucleic acids by polymerases.29,30 The search for clinically 
useful nucleoside analogues and derivatives has resulted in a wealth 
of new approaches for their synthesis, the prominent ones in recent 
years have been through enzymatic catalysis. Biocatalytic reactions 
are becoming standard procedures in their synthesis due to their 
feasibility and eﬃciency.31,32 In a similar endeavour, the 
regioselective acylation of the primary hydroxyl group of pentoses 8 
with propanoic anhydride (Scheme 1) in THF was carried out using 
Novozym 435 as a catalyst aﬀ ording exclusively 
 
 
the monoacylated derivative 9 in 95–96% yields.33 This method 
could be useful for the highly selective monoprotection of the 
primary hydroxyl group of a large variety of carbohydrate 
derivatives.34,35 
 
The regioselective acylation of secondary hydroxyl groups of 
deoxyribo- and ribonucleosides using lipases, e.g. Pseudomonas cepacea 
lipase (PSL) and lipase KWI-56 (a lipase from Pseudomonas sp.) are 
also reported in the literature.36–38 Similarly, we have also explored the 
use of lipases for the regioselective acylation of 
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Scheme 1 Lipase catalysed regioselective primary –OH group acylation of 
pentoses. 
 
 
secondary hydroxyl groups of deoxyribo-, arabino- and ribo-
nucleosides (10, 12 and 14) by a novel bacterial lipase, i.e. 
Pseudomonas aeruginosa lipase (PAL) using butanoic anhydride as 
an acylating agent affording exclusively the monoacylated 
derivatives of 11, 13 and 15, respectively (Scheme 2).39 
 
Unlocked nucleic acid (UNA) has the ribose ring open between 
the 20- and 3 0-carbon atoms and is an acyclic analogue of RNA. 
Modification of siRNA with UNA nucleotides has shown highly 
potent gene silencing activity accompanied by low cell toxicity.40,41 
For selective benzoylation of the 20-hydroxyl func-tion in 50-O-
DMT-20,30-secouridine 17 with vinyl benzoate as an acyl donor, 
several lipases were screened in diﬀ erent organic solvents. It was 
demonstrated that the Lipozyme TL IM in toluene can eﬀ ectively 
discriminate between the two primary 
 
hydroxyl groups present at the 20 and 30 positions in 50-O-DMT-
20,30-secouridine 17. This progress allowed for the development of 
an environmentally friendly and highly selective methodology for 
the eﬃcient synthesis of 20-O-benzoyl-50-O-DMT-20,30-
secouridine 18 in almost quantitative yields (Scheme 3). Compound 
18, obtained by enzymatic benzoylation, was subsequently used for 
the synthesis of 30-O-phosphoramidite 19 in a satisfactory yield, 
which is a building block for the preparation of oligonucleotides 
containing the uracil monomer of UNA.42 
 
The anomeric separation of O-aryl a,b-D-ribofuranosides is not 
feasible by conventional chromatographic methods. To overcome 
this issue, an eﬃcient and useful lipase-based method was developed 
to separate the a- and b-anomers using one of the acetoxy functions 
of peracetylated O-aryl a-D-ribofuranoside as a handle (Scheme 4). 
This methodology facilitates the easy synthesis of both, a- and b-
anomers of O-aryl D-ribofuranosides, which showed mild to medium 
antitumor activities.43 
 
2.3. Biocatalytic approach to polyol building blocks 
 
Polyols are polyhydroxy compounds and are important building 
blocks of polyurethanes and polyesters that are useful in a wide 
range of applications such as construction materials, coatings agents, 
adhesives, sealants, elastomers, and resins, etc. Enantio-selective 
transformations of these polyhydroxy compounds is 
 
 
 
 
 
 
 
Scheme 2 Lipase catalysed regioselective acylation of secondary –OH groups of deoxyribo-, arabino- and ribonucleosides. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3 Lipase catalysed regioselective acylation of UNA. 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 4 Lipase catalysed anomeric resolution of O-aryl a,b-D-ribo-
furanosides. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 5 Lipase catalysed enantioselective acylation of butane-2,3-diol. 
 
 
important considering the useful materials synthesized from these 
intermediates. An extraordinary selectivity of the lipase, Amano P to 
convert the stereoisomeric mixture, ( ) and meso 2,3-butane diol (23) 
into its (2R,3R)-diacetate 24 with 91% de and 498% ee on 
esterification with vinyl acetate (Scheme 5) shows the promising 
aspect of enantioselectivity through biocatalysis.44 
 
It has been observed that PPL and CRL allow diﬀ erentiation of 
primary and secondary hydroxyl groups. We have studied the 
regioselective transesterification of 1,2-diols 25 with the acylat-ing 
agent 2,2,2-trifluroethyl butyrate (TFEB) by using PPL and CRL. 
The reaction proceeds with high regioselectivity, 
 
 
and acylation takes place preferentially at the primary hydroxy 
groups over the secondary groups.45 In the case of compound 26, 
which has two primary and one secondary hydroxyl groups, only the 
C-30 primary hydroxyl group at the far end position to the 
asymmetric carbon gets acylated. These results are in conformity 
with the active site model of the lipase proposed by Bhalerao et al.46 
Exploring these reactions, a very high yield of sorbitol-monostearate 
was obtained through A. terreus lipase (ATL) catalysed esterification 
of sorbitol (27) with stearic acid. This involved the selective 
esterification at one of the two primary hydroxyl groups without any 
reaction at any of the four secondary hydroxyl groups.47 In our 
recent work, another biocatalytic regioselective acylation of the 
primary hydroxyl group in diols 28 and deacylation of their diesters 
30 in the presence of Lipozymes TL IM in diisopropyl ether is 
reported (Scheme 6).48 Both the acylation and deacylation reactions 
were highly selective and eﬃcient, yielding exclusively the 
monoacylated products 29 in very good yields. The biocatalytic route 
developed in these studies clearly demonstrates the superiority of 
enzymatic selective manipulation of prochiral diols and polyhydroxy 
compounds, the partial esters obtained in these studies can serve as 
useful monomers for making amphiphilic copolymers, which have 
potential utility in the health and industrial sectors. 
 
In another work, regio- and enantioselective synthesis of (S)-(+)-
3-arylamino-1-chloropropan-2-ols 32 has been achieved by the 
selective epoxide ring opening of ( )-epichlorohydrin 31 with 
diﬀ erent aromatic amines in the presence of Candida rugosa lipase 
(Scheme 7).49 Seven model (S)-(+)-3-arylamino-1-chloropropan-2-
ols (+)-32 have been evaluated for the inhibi-tion of tumor necrosis 
factor-a (TNF-a) induced expression of intercellular adhesion 
molecule-1 (ICAM-1), and have been found to exhibit up to 86% 
inhibition of TNF-a induced 
 
 
 
 
 
 
 
 
Scheme 7 Lipase catalysed enantioselective synthesis of (S)-(+)-3-
arylamino-1-chloropropan-2-ols. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 6 Lipozymes TL 1M regioselective acylation and deacylation. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
expression of ICAM-1 at a concentration of 40 mg mL 1, thus 
showing promising anti-inflammatory activity. 
 
 
3. Biocatalytic regioselective 
transesterification of polyglycerol 
 
Dendritic polymeric architectures derived from polyglycerol (PG) 
have been extensively used in the design of scaﬀ olds in several 
biomedical applications.50–52 Due to their highly biocompatible 
nature, dendritic PGs (dPGs) show a broad range of potential 
applications in medicine and pharmacology, as well as the release of 
bioactive molecules in regenerative medicine in the form of non-
fouling surfaces and matrix materials. The presence of amine groups 
on the surface or focal point in polyglycerol (PG) architectures has 
proved to be useful for provid-ing an anchoring point in the 
preparation of protein resistant surfaces,53,54 in the synthesis of 
polyglycerol (PG)-based peptide conjugates,55 macromolecular 
prodrugs (compounds that, after administration in the body, are 
converted into a pharmacologically active drug) and in the 
condensation of nucleic acid drugs.56–58 The amount and 
localization of amine groups within the PG scaffold have shown to 
have an effect on several properties related to drug coupling 
efficiency, cellular uptake, gene trans-fection efficiency,59 toxicity 
and non-specific interactions (e.g. to albumin).60 To better tune 
these properties of amino-polyglycerol compounds, it is desirable to 
develop a synthetic methodology which allows control of the 
loading and localiza-tion of the amine moieties. We have developed 
a highly efficient temperature-dependent chemo-enzymatic 
methodology for the regioselective synthesis of novel esters of 
glycerol, i.e. G1 tri-glycerol dendrons and related esters using 4-
nitrophenyl 2-(tert-butoxycarbonyl)acetate (Boc-gly-Ph-pNO2, 33) 
as the acylat-ing agent for the first time. This methodology offers 
efficient and controlled loading of amino acid (glycine) on 
polyhydroxy com-pounds. Novozym 435, porcine pancreatic lipase 
(PPL), Candida rugosa lipase (CRL), Theremomyces lanuginosus 
lipase immobi-lized on silica (Lipozyme TL IM) and Candida 
antarctica lipase-B were analysed for selective transestrification 
reactions on glycerol. Using Lipozyme TL IM in dioxane and N-
Boc-glycine 4-nitro-phenyl ester 33 as the acylating reagent for the 
selective protection of hydroxyl groups of glycerol, different 
products were formed at two different temperatures (50 1C and 70 
1C). Regioselective transesterification on glycerol under these 
conditions facilitated the formation of mono- and diesterified 
products, which were used to furnish the bifunctional G1 glycerol 
dendrons. Compounds 34 and 35 bearing four hydroxyl groups (two 
primary and two secondary hydroxyl groups) on Lipozyme-
catalyzed biocatalytic transesterification reactions using N-Boc-
glycine 4-nitrophenyl ester (33) at 50 1C for 30 h in dioxane, 
afforded compounds 36 and 37 in 81% and 76% isolated yields, 
respectively, in which only one primary hydroxyl group in both the 
cases was esterified (Scheme 8).61 The mono esters 36 and 37, when 
further subjected to Lipozyme-catalyzed transesterification reaction 
with N-Boc-glycine 4-nitrophenyl ester (33) for another 30 h at 50 
1C in dioxane, gave compounds 38 and 39 (with both the primary 
 
hydroxyl groups esterified) in 71% and 73% yields, respectively. 
The same transesterification reaction, when carried out on 
compounds 34 and 35 at 70 1C for 72 h, afforded the diesterified 
products 38 and 39 in 68% and 69% yields, respectively, with both 
the primary hydroxyl groups esterified (Scheme 8).61 
 
Using the above approach, polyglycerol-based dendritic 
amphiphiles were developed that have well-defined molecular 
structures possessing controlled glycine arrays on their surfaces (Fig. 
3).62 The structure–activity relationship with respect to siRNA 
complexation, toxicity, and transfection profiles was studied with 
synthesized amphiphilic polycations. These studies revealed that a 
second generation amphiphilic dendrimer (G2-octaamine, 43), which 
has eight amine groups on its surface and a hydrophobic C-18 alkyl 
chain at the core of the dendron, acts as an efficient vector to deliver 
siRNA and achieve potent gene silencing as shown by the 
knockdown of luciferase and GAPDH gene activity in HeLa cells.62 
Interestingly, the amphiphilic vector is nontoxic even at a higher 
ratio of N/P 100 (the ratio of moles of the amine groups of the 
cationic vector to those of the phosphate ions of DNA/RNA). To the 
best of our understanding, this was the first example of successful in 
vitro siRNA transfection using dendritic amphiphiles. We believe 
that this dendritic complex may potentially serve as a new promising 
substitute for nonviral siRNA delivery systems. 
 
 
 
4. Biocatalytic synthesis of PEGylated 
block copolymers 
 
One of the keys to the emerging advanced technologies over the past 
decade has been the use of nanomaterials. The aggressive advances 
in the fields of smart materials, solid state devices and biomimetic 
technologies, and the concurrent push towards miniaturization are 
making the understanding and development of materials at the 
nanometer level critical and encouraging. The design of nanoscale 
structures and functionalities into material systems is developing 
rapidly. The focus on nano-structuring of material systems has been 
further sharpened by the need to develop materials having novel 
and/or enhanced properties with-out resorting to new synthetic 
chemistries that have associated environmental and economic issues. 
Polymeric nanoassemblies, such as micelles of various 
morphologies, torroidal assembled polymersomes, nanofibers and 
macroscopic tubes have attracted great attention. These organized 
materials ranging from the nano to micro to macro scale have found 
broad applications in several areas, such as bioengineering, 
biomedicine, cosmetics, materials science and pharmaceutics.63–71 
In the last two decades, there has been significant growth in the area 
of enzyme catalyzed 
 
polymer synthesis for a wide variety of applications and it has been 
the subject of various reviews in the past.72–74 In particular, lipase 
catalyzed condensation polymerizations and ring-opening 
polymerizations have resulted in the synthesis of unique polymers 
for biomedical applications. However, a large number of reports in 
this area utilized commonly available monomers or building blocks, 
which in turn restricted the post-functionalization to allow broader 
applications or the ability to fine-tune the 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 8 Lipozyme catalysed transesterification of generation-1 dendrons. 
 material properties. This includes the ring opening polymer-ization 
of cyclic lactones,75 such as e-caprolactone76,77 and 
pentadecalactone78 using immobilized CAL B (Novozyme 435) to 
generate polyesters, but the lack of a handle for post-
functionalization limits their applications. Efforts to polymerize 
functional cyclic lactones or copolymerization with other func-tional 
monomers resulted in limited success.79 Similarly, enzyme 
catalyzed condensation polymerization using adipic acid, hexane 
diol and other bi-functional building blocks have been success-fully 
reported,80,81 further progress in this area focused mainly on 
designing functional diols or diacids, which offers flexibility for 
post-modification to conjugate bio-active molecules.82 Our vast 
experience of enzymatic transformations on small molecules10–
28,33–35,39,42–45,47–49
 has allowed us to utilize these extremely 
efficient and selective biocatalysts on customized monomers for 
synthesizing polymers and polymeric amphiphiles that aggregate to 
form nanospheres for various applications. Our efforts primarily 
focused on synthesizing polyethylene glycol (PEG) based block 
copolymers considering the biocompatibility of these polymers for 
biomedical applications. 
 
4.1 Biocatalytic synthesis of PEG-based drug delivery systems 
 
Targeted and controlled drug delivery utilizing carrier systems 
prepared with a wide range of synthetic and natural polymers is 
currently a very active area of research. This is due to their low half-
life, high clearance rate and non-specific actions of the 
administered drugs inside the blood stream. One of the objec-tives of 
targeted and controlled drug delivery is to reduce the amount of drug 
administered and control its non-selective distribution by using 
targeting ligands that keep the therapeutic potential high. Among the 
many nanoparticulate pharmaceutical carriers being studied for the 
delivery of extremely hydrophobic drugs, amphiphilic architectures 
are of particular interest and have significantly aﬀ ected drug 
delivery research.83,84 Our eﬀ orts in this field successfully 
employed Novozym 435 (CAL B) in synthesizing PEG based 
amphiphilic polyesters and polyamides block co-polymers utilizing 
various linkers.84,85 These polymers have been studied for their 
capability to encapsulate drugs, dyes and natural products. Candida 
antarctica lipase eﬃciently cata-lyzed the polycondensation of 
dimethyl 5-hydroxyisophthalate and polyethylene glycol of varying 
sizes in a solvent-free system. The molecular weight of the 
polyethylene glycol used strongly aﬀ ected the course of the 
polymerization reaction. In addition, the molecular weight of the 
polymer formed increased under reduced pressure and at higher 
temperatures.86,87 The present reaction system aﬀ orded a variety of 
biodegradable amphiphilic polymers via non-toxic enzymatic 
catalysis under mild reaction conditions without the use of organic 
solvents. Furthermore, the biocatalytic approach oﬀ ers the 
opportunity of post-polymerization modification of the copolymer, 
which is not feasible using conventional means. By adopting this 
methodology, we have synthesized a series of amphiphilic 
copolymers 44 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3 Structures of the PG-amphiphiles investigated. 
 
(Scheme 9) by simply attaching diﬀ erent alkoxy or acyloxy groups 
at the C-5 hydroxyl group of the polymer. Even the polymers using 
5-amino isophthalate were synthesised. It has been observed that the 
polymer that lacks any hydrophobic substituent linked to the C-5 
amino/hydroxyl group is unable 
 
to aggregate in an ordered manner, implying the need for a 
hydrophobic group at this position.84–88 
 
The amphiphilic polymers 44 aggregate in aqueous medium 
forming nanospheres of sizes 20–35 nm and act as potential drug 
delivery agents as they can encapsulate small hydrophobic drugs.88 
The influence of EDA–p interactions was also studied in the drug 
encapsulation ability of the nanospheres formed by the 
copolymers.89 To demonstrate the potential of the nanospheres 
formed by the amphiphilic polymers 45–47 as drug carriers, a 
detailed investigation was conducted on the capability of 
 
the nanospheres formed by 45 to load the anti-inflammatory agents, 
aspirin and naproxen (Fig. 4).88,89 
 
In vivo studies done by encapsulating anti-inflammatory agents 
(aspirin and naproxen) in these polymeric nanomicelles and applying 
them topically showed a significant reduction in 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 9 Lipase catalyzed copolymerization of PEG and C-5-substituted isophthalates. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4 UV absorption spectra of (a) aspirin, (b) empty nanosphere and (c) aspirin in polymeric nanosphere 45. 
 inflammation in a mice model.88 The polymers synthesized from 5-
aminoisophthalate possessing an aminoacyl chain demonstrated 
better drug loading capacity for a wide variety of bioactive 
compounds than the previously reported polymers carrying acyloxy 
chains (Scheme 10).90 
 
The copolymers 50–56 were evaluated for their drug encapsu-
lation capacity using curcumin, a bio-active naturally occurring 
compound of current interest in chemical and biological research 
worldwide. The synthesized polymers having long alkyl chains 
attached via an ether linkage, viz. 50–53 demonstrated a better 
curcumin loading capacity than the identical polymers having a long 
acyl chain attached via an ester linkage, viz. 54–56. Particle sizes 
were found to be in the range of 20–50 nm for polymers 50–54 and 
56, whereas polymer 55 showed a particle size of ca. 88 nm (Fig. 5). 
There was no significant change in the particle size of these 
amphiphilic polymers after encapsulation of curcumin, except for 
polymer 50.91 
The selective interactions of the phenolic moiety of our 
PEGylated polymers with alkali and alkaline earth metal ions 
were investigated, and Ca2+ ions were found to preferentially bind to 
the co-polymers 57a–c constituted by the phenols and PEG (Fig. 
6).92 The advantage of using the PEG unit is that it confers solubility 
to these aromatic polyester polymers (57a–c and 58–60) in aqueous 
medium. These polymeric systems can be used for selective 
detection and estimation of Ca2+ ions in the presence of other 
cations. This may have promising applications in the field of 
analytical biochemistry.92 
 
The guanidine-based polymeric system 61 (Fig. 7) has been 
developed with the aim that these cationic polymers will increase the 
cellular uptake and may prove to be useful for gene delivery as they 
can undergo interactions with the negatively charged phosphate 
groups of the DNA/RNA/cell surface.93 
 
In addition to the copolymerization approaches discussed above, 
terpolymerization reactions have also been performed by some 
research groups to synthesise novel drug delivery carriers using 
poly(ethylene glycol) (PEG), sebacic acid (SA) and 1,3-bis-
(carboxyphenoxy)propane (CPP) as the monomers.94 The synthesis 
of a novel class of terpolymers was accomplished by us through 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 10 Functionalization of 5-hydroxy and 5-amino groups of the polymer 48. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5 Functionalized amphiphilic polymers. 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6 Enzymatically catalyzed polymers for the selective Ca2+ ion binding studies. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 7 Guanidine-functionalized copolymers. 
 
 
incorporation of a third component during the copolymerization of 
dimethyl 5-hydroxyisophthalate with poly(ethylene glycol 600) 
under solventless conditions using Novozym-435.95 These multi-
component polyesters and mixed polymers with polyester and 
polyamide linkages have aromatic as well as aliphatic moieties 
incorporated into their backbone. The properties of these 
terpolymers were compared and studied vis-a`-vis the addition of the 
third component having diﬀ erent functionalities, i.e. com-pounds 
1,6-hexanediol, 1,6-hexanediamine or 1,6-hexanedithiol 
 
 
during terpolymerization reaction of dimethyl 5-hydroxyiso-
phthalate with polyethylene glycol (Scheme 11).95 
 
Vitamin E is known for its ability to capture the energetic free 
radicals (reactive forms of oxygen) and therefore to help combat 
their potential skin damaging eﬀ ects. Unfortunately, it is diﬃcult for 
the vitamin E molecule to penetrate and spread through the outer 
layers of skin on its own. We have designed and synthesized novel 
nano-carriers for incorporating vitamin E (Fig. 8).96,97 These 
nanocarriers with covalently linked vitamin E moieties have 
enhanced capacity to encapsulate vitamin E. Such systems are 
unique due to the presence of both bound as well as encapsulated 
vitamin E, and this allows a better control over the release and 
bioavailability of vitamin E. The amphiphilic nature of these nano-
carriers make them soluble in both hydrophilic and lypophilic 
media.96,97 
 
The vitamin E conjugated copolymers 64 are highly soluble in 
water but do not aggregate to form nano-micelles as observed using 
a static light scattering technique. This may be due to the improper 
balance of hydrophilic to hydrophobic segments. Therefore, the 
partially (30%) vitamin E conjugated copolymers 64 were further 
reacted with excess of bromodecane to completely 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 11 Chemo-enzymatic multi-component copolymerization. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8 Vitamin E incorporated amphiphilic nanocarriers. 
 
 
 
substitute the phenolic hydroxyl groups to get polymers 65 as shown 
in Fig. 8.96,97 
 
To enhance the eﬃcacy of chemotherapeutic agents, it is 
pertinent to develop a methodology, which can target only malignant 
cells. With this aim, we have synthesized a novel polymeric nano-
carrier/bioconjugate 66 containing the highly lipophilic 
pentadecapeptide (EPPT), which selectively binds to the pancreatic 
cancer cells. These nano-carriers can potentially act as 
‘‘theranostic’’ agents as they have the capacity for selective cell 
uptake and can provide a method for MRI in cancer 
therapy/diagnosis. Thus these nano-carriers should be capable of not 
only imaging cancer cells but also providing selectivity as a 
therapeutic for destroying cancerous cells. The synthesized polymer 
nano-carriers 66 (Fig. 9) are highly soluble in water and organic 
solvents, thus making them suitable for both aqueous and non-
aqueous preparations. Initial in vitro studies examining the cellular 
uptake of these nano-carriers by radioactive labelling and analysis 
have 
 
 
shown some selectivity of these nano-carriers for targeted 
(pancreatic) cancer cells over non-targeted cells.98 The key problem 
in the treatment of cancer is the limitation with current imaging 
techniques for detecting cancer in the very early stages and treating 
it. To address this issue, a nano-platform, capable of not only 
imaging cancer cells but also delivering the therapeutics for 
destroying these cancerous cells, was developed.98 
 
There is tremendous interest in controlled release formulations 
for their potential in reducing the use and impact of pesticides/ 
insecticides in the environment. Controlled release of a desired 
pesticide/insecticide may be achieved by covalently attaching them 
either as a pendant group or as part of the polymer backbone through 
a labile link, to regenerate the biocide by hydrolysis or by enzymatic 
degradation.99 Copolymers of polyethylene glycol and various 
dimethyl esters were synthesized using the procedure mentioned 
previously. These co-polymers self-assemble into nanomicellar 
aggregates in 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 9 Polymeric nano-carriers 66 containing the EPPT peptide. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 12 Synthesis of copolymers 67 used for carbofuran encapsulation. 
 
 
 
aqueous media and were used for the encapsulation of carbo-furan 
(2,3-dihydro-2,2-dimethylbenzofuran-7-yl methylcarba-mate), an 
insecticide-nematicide. Thus, a controlled release formulation 
(Scheme 12) has been developed, perhaps for the first time, where 
amphiphilic nanopolymers have been used for the development of a 
controlled release pesticide application.99 
 
 
4.2 Biocatalytic synthesis of pluronic based polymers 
 
The poly(ethylene oxide)–poly(propylene oxide) (PEO–PPO–PEO) 
triblock copolymers family of pluronics, with different numbers of 
hydrophilic ethylene oxide and hydrophobic propylene oxide units, 
have an adequate hydrophilic–lipophilic balance. Due to their 
amphiphilic character, these copolymers display surfactant 
properties including an ability to interact with hydrophobic surfaces 
and biological membranes. We have synthesized amphi-philic 
pluronic-based copolymers using CAL-B.100 The developed 
 
 
polymeric materials 68 and 69 were found to be capable of 
solubilizing/encapsulating the hydrophobic drug curcumin (Scheme 
13). The percentage solubilization/encapsulation of curcumin was 
found to be in the range of 2.7–5.7% with respect to the weight of 
the different polymers used. The percentage 
 
encapsulation of curcumin was estimated using UV spectroscopy in 
methanol.100 
 
4.3 Biocatalytic synthesis of PEG dimethyl fumarate and 
dimethyl maleate based polymers 
 
An enzymatic copolymerization of PEG with dimethyl fumarate and 
dimethyl maleate under solventless conditions provided the 
corresponding copolymers 70 and 71, respectively (Scheme 14).101 
Though no cis/trans isomerization was observed under enzymatic 
polymerization conditions, the saturation of double bonds remains a 
problem similar to that observed in the chemocatalyzed 
polymerization of these esters. A terpolymerization of dimethyl 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 13 Biocatalytic synthesis of pluronic based polymers. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 14 (a) Copolymerization of PEG-dimethyl fumarate. (b) Copolymerization of PEG-dimethyl maleate. (c) Terpolymerization. 
 
 
 
 
fumarate, dimethyl maleate and PEG was also carried out to give the 
terpolymers 72.101 
 
4.4 Biocatalytic synthesis of copolymers of PEG and non-
proteinogenic amino acid derivatives 
 
Amino acids, the building blocks of all proteins, are biochemically 
involved in every biological process and thus make them essential 
for human life. They are non-toxic, biocompatible and economical. 
Their high cellular permeability and fixed stereochemistry prompted 
us to use them as building blocks for polymer synthesis.102 Also the 
great versatility and the inherent high aﬃnities of peptides for their 
respective targets have led to tremendous progress for their 
therapeutic application in the last few years. In order to enhance 
their utility in therapeutic applications, their chemical modifications 
are of great interest. One of the approaches to modulate their 
pharmacokinetic properties is the frequently used PEGylation 
methodology.103 In light of the above, we have carried out lipase 
catalyzed con-densation copolymerization of a number of non-
proteinogenic amino acid derivatives and polyethylene glycol (PEG, 
MW 600) in bulk (Scheme 15).102 
 
4.5 Biocatalytic synthesis of glycerol–PEG based copolymers 
 
Glycerol is one of the most versatile and valuable chemical 
substances and is utilized in a variety of commercial products with 
no known adverse pharmacological or environmental eﬀ ects. 
Moreover, it exhibits good chemical stability and inertness in 
biological systems. We have designed and developed the Novozym 
435 catalyzed biocatalytic method to synthesize novel polymeric 
systems 74 using glycerol and poly[ethylene glycol 
bis(carboxymethyl)ether] dimethyl ester.104 Both the synthons 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 15 Biocatalytic synthesis of PEG and non-proteinogenic amino 
acid copolymers. 
 
 
used in the co-polymer synthesis are biocompatible, non-toxic and 
are readily available. The polymerization proceeds regio-selectively 
through the primary hydroxyl groups of glycerol leaving the 
secondary hydroxyls free for post-coupling with saturated fatty acid 
esters, or possibly coupling with drugs/bioactive molecules. 
Amphiphilic polymers 75 were synthesised by attaching alkyl chains 
at the secondary hydroxyl groups of these PEG–glycerol co-
polymers simply by acylation (Scheme 16).104 
 
The synthesised amphiphilic polymers 75a–c show aggregation 
under aqueous conditions, thus forming nanoparticles in the range of 
ca. 51.7–57.1 nm size and the critical micelle con-centration (CMC) 
value of the polymer 75c in aqueous media was determined using a 
static light scattering technique, and was found to be 0.024 M. The 
supra-molecular organization 
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Scheme 16 Lipase catalysed synthesis of glycerol–PEG based copolymers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 17 Chemoenzymatic synthesis of PEG and amino acid diester 
based copolymers. 
 
Fig. 10 UV absorption spectra of an encapsulated hydrophobic drug 
vitamin E in the copolymer 75c using methanol as a solvent. 
 
 
 
of polymers 75a–c in aqueous and organic media was studied using 
static light scattering. The drug encapsulation capability of these 
polymeric systems was evaluated by attempting the encapsulation of 
hydrophobic vitamin E, the percent-age encapsulation of vitamin E 
was found to be quite satis-factory viz. 22% with respect to the 
weight of the polymer (Fig. 10).104 
 
 
 
4.6 Biocatalytic synthesis of PEG and amino acid diester based 
copolymers 
 
To synthesize amphiphilic copolymers based on amino acid diesters 
and PEG, a chemo-, regioselective enzymatic method-ology was 
designed. The condensation polymerization was catalyzed by 
immobilized Candida antarctica lipase (Novozym 435) under 
solventless conditions. The free amino group after copolymerization 
was functionalized with acyl chloride (Scheme 17). The availability 
of a free amino group after 
 
copolymerization is a significant achievement in terms of polymer 
therapeutics.105 
 
4.7 Biocatalytic synthesis of sugar-PEG based copolymers 
 
Novel sugar-PEG-based polymers 78–80 were synthesized by the 
enzymatic copolymerization of 4-C-hydroxymethyl-1,2-O-
isopropylidene-b-L-threo-pentofuranose/4-C-hydroxymethyl-1,2-O-
benzylidene-b-L-threo-pentofuranose/4-C-hydroxymethyl-1,2-O-
isopropylid-ene-3-O-pentyl-b-L-threo-pentofuranose with PEG-600 
dimethyl ester using Novozyme-435 (Scheme 18).106 
 
Carbohydrate monomers were obtained through a multi-step 
synthesis starting from D-glucose diacetonide, and PEG-600 
dimethyl ester was obtained by the esterification of the commercially 
available PEG-600 diacid. Aggregation studies on the copolymers 
78–80 revealed that in aqueous solution, those polymers bearing the 
hydrophobic pentyl/ benzylidene moiety, viz. 79,80, spontaneously 
self-assemble into supramolecular aggregates. The polymeric 
aggregates were further explored for their drug encapsulation 
properties in buffered aqueous solution of pH 7.4 (37 1C) using Nile 
red 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 18 Biocatalytic synthesis of Sugar-PEG based copolymers. 
 
as a hydrophobic model compound by means of UV/Vis and 
fluorescence spectroscopy.106 
 
 
4.8 Biocatalytic synthesis of PEGylated curcumin block 
copolymers 
 
Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is a central 
transcription factor that regulates the antioxidant defense system and 
is considered as a modifier for several inflammatory diseases. Thus, 
activation of Nrf2 provides a pivotal therapeutic target for 
developing therapies against these diseases. Herein, a chemo-
enzymatic methodology has been designed and developed to make 
PEGylated curcumin derivatives as water soluble drug candidates 
with enhanced aqueous solubility and bioavailability. For this, the 
curcumin diester 81 was copolymerized with poly(ethylene glycol) 
(82) using Novozym 435 under solventless conditions (Scheme 
19).107 Novozym 435 promotes selective trans-esterification and 
only catalyses the reaction of the primary hydroxyls of poly(ethylene 
glycol). It does not aﬀ ect the secondary enolic hydroxyls of 
curcumin, thus leaving the active moiety in curcumin unaltered. A 
luciferase based reporter gene assay was used during primary 
screening for establishing the anti-inflammatory activity of this 
novel Nrf2 activator. Most of the PEGylated curcumin analogs 83a–
d strongly activate Nrf2 several folds higher than the free curcumin 
but copolymer 83a was identified as the most potent Nrf2 activator. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 19 Synthesis of PEGylated curcumin block copolymers. 
 
 
Copolymer 83a induces Nrf2-driven NQO1 expression in a 
concentration dependent manner.107 
 
5. Biocatalytic synthesis of 
photoresponsive amphiphilic polymers 
 
Photochemical reactions, which occur in small molecules, can also 
be induced to occur in macromolecules. Though in 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 11 Photochemical reaction in the cis–trans isomerism of an 
azobenzene. 
 
 
macromolecular environments, there are constraints which are not 
present in the small molecules, the challenge is to apply fundamental 
principles to macromolecules which may coil, branch, or be 
chemically cross linked increasing the order of complexity. 
Likewise, molecular mobility plays an important role in determining 
the course of photochemical behaviour in polymers and is related to 
the size of the molecule, the flexibility of the polymer chain, and 
whether the polymer is in solution or in the solid state. 
 
We have designed and synthesized photo responsive amphi-
philic polymers using a novel chemo-enzymatic methodology to 
study their supra-molecular organization in aqueous and organic 
media so that their supramolecular organization can be changed in a 
controlled manner.108 
 
Azobenzene-containing polymers have attracted considerable 
attention in the last decade due to their potential applications as 
photoactive compounds for molecular devices, information storage 
systems and photochemical switching (Fig. 11). Keeping this in mind, 
the copolymer 86 was synthesized through the Candida antarctica lipase 
B (Novozym 435) catalyzed condensation polymerization of dimethyl 5-
hydroxy isophthalate with polyethylene glycol as discussed earlier, and 
alkylated with azo benzenes 87–90.108 The resulting polymers 91–94 
were studied for their cis/trans isomerization behavior upon UV 
irradiation (Scheme 20). 
 
Progress was also made in the development of a novel chemo-
enzymatic approach for the covalent attachment of photoresponsive 
units into the RNA backbone.109 This involved lipase catalyzed 
acylation of the C-20 hydroxyl group in the ribose sugars in the 
RNA molecule to incorporate photo-isomerizable azobenzene 
groups into the RNA strands (Scheme 21). A reverse micellar 
approach was used for this RNA functionalization to maintain the 
solubility of the nucleic acid as well as to limit the preferred 
 
hydrolysis reaction in aqueous media. The azobenzene groups 
incorporated into the RNA molecule show photo-isomerization 
behavior and can serve as optical ‘handles’ for the manipulation of 
the conformation of RNA. The photoactive group incorporated into 
the RNA molecule opens new avenues for the investigation of RNA 
conformational switching through the photodynamic behavior of the 
azo chromophore as well as for the fabrication of versatile functional 
biomacromolecular matrices.109 
 
In another report, photoresponsive polymeric amphiphiles 96a–b 
(Fig. 12) have been developed by first synthesizing the polyester 
chain via Novozym 435 (CAL B) catalyzed condensation 
polymerization of poly[ethylene glycol bis(carboxymethyl)ether]-
diethylester and 2-azidopropan-1,3-diol. The resulting polymers 
96a–b aggregated in aqueous media to form supramolecular micellar 
aggregates as shown by fluorescence measurements using ‘Nile red’ 
as a probe. The nano-structures formed in the aqueous solution were 
studied using dynamic light scattering and cryo-TEM measurements. 
The encapsulation potential of poly-meric amphiphiles for Nile red 
and curcumin as well as their release via cis–trans 
photoisomerization of the embedded azobenzene moiety was studied. 
The developed polymeric micellar systems behave as efficient 
photoresponsive smart nanocarriers.110 
 
6. Polymeric electrolytes for 
nanocrystalline solar cells 
 
Dye-sensitized solar cell (DSSC)-devices based on molecular dyes 
are reported to be capable of injecting electrons into the conduction 
band of oxide semiconductors in their photo excited state, and are 
currently attracting wide interest due to their potential for converting 
solar light into electricity at a low cost. A variety of tethered 
PEGylated polymers were developed using a mild, environmentally 
benign and highly selective biocatalytic approach for preparing a 
quasi-solid electrolyte system for dye-sensitized solar cells (DSSCs). 
The biocatalytic approach was based on Novozyme-435 catalyzed 
copolymerization reactions; the polymeric materials obtained were 
further function-alized with hydrophobic and hydrophilic side chains 
using mild chemical reactions (Scheme 22),111 and the resulting 
polymeric 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 20 Synthesis of photoresponsive amphiphilic polymers 91–94. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 21 Synthesis of azo functionalized RNA. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 12 Synthesis of an azobenzene functionalized polymer and its dendronized analogue. 
 
 
 
materials were used in formulating quasi-solid electrolyte compo-
sitions and incorporated into flexible DSSCs. Quasi-solid electro-
lytes prepared from biocatalytically synthesized polymers 97a–c 
(Scheme 22) by adding at least 25% of the polymer in an ionic-
liquid-based electrolyte composition showed a PV efficiency of 
4.30%. Almost identical results (PV 4.45%) were observed from the 
cells containing an ionic-liquid-based electrolyte that did not contain 
the polymers 97a–c, thus indicating that the presence of polymers 
97a–c has no adverse effect on the conversion efficiency. In contrast, 
it increases the stability of the devices as it forms a gel 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 22 Chemoenzymatic synthesis of PEGylated polymer 97a–c. 
 
and does not contain any volatile solvent. The measured 
 
ionic conductivity of the formulation used in these devices is B2 10 5 
Siemens(S) per cm.112 
 
The ionic conductivity is not an intrinsic property of the PEG 
polymer but depends on the details of the formulation used. The 
results from photovoltaic characterization studies on polymers 97a–c 
based gel electrolytes incorporated into flexible solar cells show that 
the photovoltaic (PV) performance is similar, irrespective of the 
viscosity of the polymer electrolyte at similar polymer 
concentrations. This is a very promising result, as the viscosity of the 
gel can be altered without affecting the PV performance of the solar 
cells. The intensity-dependent PV characterization study suggests 
that maximum PV perfor-mance is achieved at an intensity level of 
around 0.5 Sun (50 mW cm 2). An efficiency of over 4.6% was 
achieved for the polymer 97c based gel-incorporated flexible cell at 
55 mW cm 2, which is about 10% higher than under the 1 Sun 
condition.111,113 
 
The ion transport properties and photovoltaic performance of 
polymers 98a–d (Fig. 13) – based on quasi-solid electrolytes 
incorporated photo voltaic cells – have also been studied. The 
polymeric electrolytes 98a–d were synthesized through the 
Novozym-435 catalyzed copolymerization of dimethyl 5-
hydroxyisophthalalte and poly(ethylene) glycol of various sizes as 
described earlier. These polymers were incorporated into Konarka’s 
redox electrolyte formulations and were applied onto dye sensitized 
titanium oxide coated plastic substrates. After applying the 
electrolyte, the dye-sensitized titanium oxide 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 13 Enzymatically synthesized polymeric electrolyte. 
 
 
coated flexible substrate was sandwiched with a platinum coated 
ITO/PET substrate and heat-sealed to obtain flexible plastic cells. 
The fabricated cells were characterized for photo-voltaic (PV) 
performance using a solar simulator under AM 1.5 conditions. It was 
observed that the solar conversion efficiency of the solar cells 
depended strongly on the polymer micro-structure used in 
formulating the redox electrolyte and showed a photovoltaic 
efficiency up to 3.0%.114 
 
 
 
 
7. Biocatalytic synthesis of PEG 
coumarin block copolymers 
 
4-Methylcoumarins are well known for their antioxidant and anti-
edema activities. 
 
To increase their antioxidant potential and hydrophilicity, lipase 
(Novozym 435) catalyzed polymerization of C-4 methyl-coumarin 
diesters and polyethylene glycols (PEGs) was carried out to produce 
the novel copolymers 99 (Scheme 23).115 These novel PEGylated C-
4 methyl- and C-4, C-8 dimethylcoumarin derivatives were 
evaluated for their ability to lower ICAM-1 (intercellular cell 
adhesion molecule-1, whose overexpression leads to inflammation) 
expression.115,116 
 
In another approach, the C-4 methyl- and C-4, C-8 dimethyl-
coumarins were attached covalently to the PEG-based copolymers 
100 (obtained through CAL-B catalyzed copolymerization as 
discussed earlier) (Scheme 24).116 The synthesized derivatives were 
evaluated for their anti-inflammatory activities with respect to their 
ability to inhibit TNF-a induced ICAM-1 (intercellular cell adhesion 
molecule-1) expression on human endothelial cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 23 Synthesis of PEGylated C-4 methylcoumarins. 
 
 
 
 
 
Scheme 24 Coupling of bromo analogues of C-4 methyl- and C-4, C-8 
dimethyl coumarins with PEGylated polymers. 
 
 
It was observed that the PEGylated 4-methyl- and 4, 8-dimethyl-
coumarin derivatives were more eﬀ ective than their non-PEGylated 
analogues in inhibiting ICAM-1 expression. The PEGylated 4-
methyl- and 4,8-dimethylcoumarins have shown an enhanced and 
improved ability to inhibit TNF-a induced ICAM-1 expression on 
human endothelial cells as compared to the monomeric analogues. 
The additional advantage of synthesized PEGylated co-polymers is 
their enhanced solubility in aqueous and organic media, thus making 
them suitable for bio-medical preparations and applications.116 
 
Coumarins comprise a very large class of phenolic compounds 
and are well known for their optical properties. Copolymers were 
synthesized using PEG and polydimethyl siloxane (PDMS) con-
taining coumarins for the detection of DNT and TNT (Fig. 14). The 
fluorescence quenching of these co-polymers in solution can be 
attributed to the collisional quenching. The fluorescence quenching 
of 50 nm-thick films of these co-polymers is 60% and 20% due to 
DNT and TNT vapours, respectively, at room temperature. The 
significant quenching of fluorescence for 50 nm-thick films is 
attributed to the low glass transition temperature of PEG and PDMS 
which provides pathways for analyte diﬀ usion even at room 
temperature and consequently sensitivity is not limited to the analyte 
diﬀ usion. This approach is simple but unique and could be extended 
to other chromo-phores sensitive to the detection of explosives. The 
response of these polymeric sensors 102 and 103 is promising, and 
they can easily detect DNT and TNT at the level of a few parts per 
billion.117 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 14 (a) Co-polymer of C-4, C-8 dimethylcoumarins with PEG and (b) 
co-polymer of C-4, C-8 dimethylcoumarins with PDMS. 
 
8. Biocatalytic synthesis of dendronized/ 
hyperbranched PEG co-polymers 
 
We have developed a novel and eﬃcient chemo-enzymatic route for 
building novel amphiphilic dendritic polyglycerol (dPG) archi-
tectures. Novozym-435 catalyzed PEGylation of dPG occurred in a 
regioselective manner at the primary hydroxyl groups in the 
presence of secondary hydroxyl groups. The remaining (secondary) 
hydroxyl groups were acylated to develop amphiphilic dPG 
architectures. The amphiphilic polymeric architectures 104–106 
(Fig. 15) showed a transport capacity for guest molecules, like Nile 
red, thus demonstrating their suitability for the solubilization of 
hydrophobic drugs. These systems have demonstrated their ability to 
release the encapsulated Nile red at pH 5.0 (endosomal pH), while 
no release was observed at pH 7.4 (physiological pH). Furthermore, 
cell viability studies of these polymers showed that they are 
relatively non-toxic. These successful efforts in tuning the synthesis 
and physico-chemical properties of dPG-based 
 
amphiphilic polymeric architectures as novel drug delivery systems 
are currently being explored as biodegradable dendritic nano-carriers 
for biomedical applications.118 
 
Polyglycerol scaﬀ olds and nanoparticles have emerged as 
prominent materials for various biomedical applications including 
topical drug delivery. The impact of polymer struc-tural 
modifications on the properties of the nanoparticles viz. the drug 
delivery potential and biocompatibility are not fully understood. We 
have explored the influence of structural modifications of 
structurally related polyglycerol based nano-particles (PG–PEG) on 
dermal drug delivery efficiency and biocompatibility. The PG–PEG 
particles (Fig. 16) with varying particle sizes were synthesized via 
chemo-enzymatic approaches and their interactions with guest 
molecules were studied. Con-siderably improved dermal drug 
delivery was shown by the smallest particles 108 and 109 (11 nm 
and 14 nm size), and this correlated with the well-defined surface 
properties of the alkylated particles. The consistently good 
biocompatibility of all the PG–PEG particles was mainly attributed 
to their neutral surface charge. No irritation, major cytotoxicity or 
genotoxicity were observed with these novel nanoparticles. 
Nevertheless, slightly better biocompatibility was seen for the 
particles that had alkyl chain substituents in the core and not on the 
particle surface. Despite the high structural similarity of the PG–PEG 
particles, their functionalization significantly influenced the particle 
properties, in particular biocompatibility, and most signifi-cantly the 
drug delivery efficiency.119 
 
Haag et al. reported the synthesis of a bifunctional nano-carrier 
system based on amphiphilic hyperbranched polyglycerol (hPG), 
which was further modified by introducing hydrophobic aromatic 
groups in the core and retaining hydrophilic groups in the 
shell.120,121 ‘‘Selective chemical diﬀ erentiation’’ and lipase 
catalyzed chemo-enzymatic reaction strategies were utilized to 
synthesize these new core–shell type nano-carriers (Scheme 25). The 
system shows an innovative bifunctional carrier capacity with both 
polymeric and unimolecular micelle-like transport properties. 
Hydrophobic guest molecules such as pyrene were encapsulated into 
the hydrophobic core of modified hPG via 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 15 Biocatalytic synthesis of amphiphilic hyperbranched polyglycerols Fig. 16 Controlled synthesis of the PG–PEG nanoparticles for dermal 
 
104–106 and their Nile red encapsulation/release. drug delivery applications. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 25 Bifunctional nanocarrier systems based on amphiphilic hyperbranched polyglycerol (hPG). 
 
 
hydrophobic interactions as well as p–p stacking, analogous to a 
unimolecular micelle system. A second guest molecule, which has a 
high affinity for the shell, like Nile red, was solubilized in the outer 
shell of the host molecule, thus connecting the nanocarrier molecules 
forming aggregates. This model is confirmed using UV-Vis, 
fluorescence, atomic force microscopy, and dynamic light scattering, 
as well as release studies triggered by pH-changes and enzymes. 
Different control release profiles were observed for the encapsulated 
guest molecules in the core and in the shell. The bifunctional 
nanocarrier system is a promising carrier system for concurrent 
delivery of more than one hydrophobic drug for combination 
therapies.120 
 
The biocatalytic synthetic approach has also been utilized for the 
creation of a new class of non-ionic dendronized multiamphiphilic 
polymers and their self-assembly to micellar nanocarriers has been 
studied. The polymers were constructed from biocompatible PEG 
chains and PG dendrons to form a hydrophilic outer shell and alkyl 
chains molding for a hydro-phobic interior. The polymer backbone 
was synthesized from linear PEG and 2-azido-1,3-propanediol using 
a biocatalytic pathway. The versatility of this basic structure 
originates from its azido groups, which facilitate an easy 
functionalization by Click grafting with appropriate alkynes. As a 
proof of concept, the polymeric backbone was grafted with 
polyglycerol dendrons of diﬀ erent generations and octadecyl chains 
in varying proportions, and this led to a series of new multi-
amphiphilic polymers 117a–f that self-assemble to generate well-
defined, globular micelles with diameters in the range of 10 nm at 
low critical aggregation concentrations (10 5 M) as was shown by 
the DLS, cryo-TEM and surface tension measurements (Fig. 17). 
The potential ability of these micelles to function as nanocarriers and 
as prospective drug delivery systems was illustrated with the 
hydrophobic model dye pyrene.121 
 
 
In another study, the synthesis of PEG-1000-diethyl ester and 2-
azido-propane-1,3-diol-based copolymers has been achieved 
utilizing Novozym 435. The linear base copolymer was then 
functionalized with polyglycerol-based regular [G1.0] and [G2.0] 
dendrons and C12/C14 hydrophobic alkyl chains via an eﬃcient 
Click Chemistry approach (Scheme 26). The resulting amphiphilic 
dendronized polymers 118a–d form well-defined 
 
micelles in aqueous solutions. The transport behavior of these 
polymers was studied by using Nile red as a fluorescent model dye. 
The cytotoxicity profiles of a few representative polymers were 
evaluated, and the effect of hydrophobic alkyl chain length as well as 
hydrophilic polyglycerol dendron’s genera-tion on the 
biocompatibility of the polymeric systems was studied.122 
 
To gain further insight into the factors that aﬀ ect stability and 
transport eﬃciency under dilution conditions, dendronized and 
hyperbranched multifunctional amphiphilic polymers were 
synthesized by following the ‘‘grafting to’’ approach using varied 
amounts of propargylated alkyl chain with perfect and hyper-
branched polyglycerol dendrons on the base copolymer of PEG (Mn: 
1000 g mol 1) diethylester and 2-azidopropane-1,3-diol following the 
biocatalytic method and Click Chemistry approach. The dendronized 
and hyperbranched polymeric sys-tems form supramolecular 
aggregates and exhibit an eﬃcient transport potential for the model 
dye ‘‘Nile red’’ in the low mM range in the core–shell-type 
architecture provided with distinct amphiphilicity as required for 
encapsulation (Scheme 27).123 Cytotoxicity studies show the 
polymeric systems to be non-toxic over a wide concentration range. 
The cellular internalization of Nile-red-encapsulated supramolecular 
micellar structures was also studied using cellular fluorescence 
microscopy and fluorescence-activated cell sorting (FACS) 
measurements. A comparison of the data for the dendronized 
polymers (PEG Mn: 600/1000 g mol 1) with the respective low-
molecular weight amphiphiles reveal that these polymeric systems 
are excellent nanotransporters.123 
 
In another approach, a new class of amphiphilic molecular 
transporters has been developed through the Novozym 435 catalyzed 
copolymerization of PEG diethyl ester and azido-triglycerol via its 
primary hydroxyl groups. The co-polymer was further grafted by 
using the C12 alkyl chain and polyglycerol dendron moieties via the 
azide group of the polymer backbone by following the ‘Click’ 
chemistry approach (Fig. 18). The secondary hydroxyl groups on the 
backbone provide an additional site for acylation and fine-tuning the 
physico-chemical properties. The encapsulation potential of these 
polymeric architectures was explored for Cy3 dye. Although most of 
the amphiphilic polymers form stable micelles, polymer 120a 
behaved diﬀ erently in terms of 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 17 Biocatalytic synthesis of dendronized multi-amphiphilic polymers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 26 Synthesis of multifunctional amphiphilic dendronized polymers 118a–d. 
 
 
 
aggregation as it exhibits the formation of vesicles along with 
micelles. However, all the polymers show a significant Cy3 
transport capacity in the range of 7.5–19.1 mmol mol 1 of polymer. 
The cellular internalization and in vitro study of dendronized 
polymers by means of CLSM measurements revealed that the [G2.0] 
grafted polymer 120c exhibits better transport results.124 
 
 
9. Biocatalytic synthesis of novel 
polymeric antioxidants 
 
Many industrial products such as plastics, elastomers, lubricants, 
petroleum-based products, cooking oil, cosmetics, as well as 
processed food products undergo oxidative, mechanical, thermal and 
photo degradation. The primary cause of degradation has 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 27 Synthesis of multifunctional amphiphilic dendronized polymers. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 18 Amphiphilic dendronized polymers 120a–c for encapsulation and 
cellular internalization of cyanine dye. 
 
 
been recognized to be an auto-oxidation process resulting from the 
generation of energetic free radicals following mechanical, thermal 
or photo stress. These free radicals degrade the materials. Synthetic 
antioxidants are normally added to almost all poten-tially oxidizable 
organic and industrial materials. The antioxidant molecules act 
rapidly to scavenge these energetic free radicals thus preserving their 
properties and extending their useful shelf life.125 Although 
conventional antioxidants provide pro-tection against the deleterious 
eﬀ ects of energetic free radicals, they have some serious drawbacks, 
such as poor thermal stability, high volatility, poor processabilty, 
etc. owing to their molecular size.126–130 Various approaches have 
been followed to make high-molecular-weight macromolecular 
antioxidants. These high-molecular-weight antioxidants have 
improved extraction and 
 
migration resistance and thermal stability and processability, but 
their antioxidant activity performance suffers greatly.131–133 
Realizing some of these deficiencies, Cholli and his research team, 
firstly at the University of Massachusetts Lowell and later at Polnox 
Corporation have developed a new class of high molecular weight 
antioxidants using biocatalytic methodology, possessing significantly 
higher antioxidant properties and improved thermal stability.84,134–
140
 Several commercially avail-able monomeric mono-, di- and 
trihydric phenolic antioxidant compounds (some of which have 
commercial applications), after suitable modification using lipase-
catalysed reactions, were polymerized with horse radish peroxidase 
(HRP) or a cheaper chemical reagent to generate a new class of 
polymeric antioxidants that have superior properties compared with 
the starting monomeric compounds (Scheme 28).135–141 These 
phenolic polymers showed a superior antioxidant performance and 
exceedingly remarkable applications in preserving petroleum 
products, cosmetics, cooking and edible oils, lubricants, polymeric 
materials, automobile oils, gasoline, meat and dairy products, etc. in 
increasing their shelf life and performance.141 Many of these novel 
polymeric antioxidants have been synthesized in bulk amounts and 
tried in the various industrial sectors mentioned above, and they have 
shown superior performances and are being developed for 
commercial applications. 
 
These polymeric antioxidants have proved to be vital additives to 
protect materials against oxidation. There are various kinds of 
antioxidants available to improve the shelf life of a wide range of 
organic materials. Improving the eﬃcacy of antioxidants is essential 
in extending the life of useful finished products and materials. In this 
eﬀ ort, we have successfully documented that these novel polymeric 
antioxidants oﬀ er superior antioxidant activities with significantly 
improved thermal stability.135–141 These polymers have been 
synthesized via an environmentally benign chemoenzymatic 
methodology using two enzymes, viz. a lipase (Novozym 435) and 
an oxidase (HRP) (Scheme 28). 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 28 Biocatalytic synthesis of poly(t-BHQ). 
 
 
10. Biocatalytic approach for 
developing novel organosilicon 
polymers as flame retardants (FRs) 
 
Flame retardants (FRs) comprise a diverse group of chemicals which 
are widely used at relatively high concentrations and find many 
applications, including in the manufacture of electronic equipments, 
textiles, plastics, polymers and in the aviation and automobile 
industries.142 The global annual consumption of flame retardants is 
currently over 1.5 million tons with a market value of over 6 billion 
dollars. The use of FRs is primarily to protect materials against 
ignition and to limit (or prevent) fire related damages. More than 
175 diﬀ erent types of FRs exist and are commonly divided into four 
major groups: inorganic FRs, organophosphorus FRs, nitrogen 
containing FRs and halogenated organic FRs.143 The mode of 
incorporation into the polymeric material divides the FRs into two 
additional classes, namely reactive or additive. Reactive FRs are 
chemically bonded into plastics, i.e. HET acid, TBBPA, DBNPG or 
other organophos-phorus compounds. Additive FRs are numerous 
and more frequently used. They are blended with the polymers and 
thus are more likely to leach out of the products, e.g. HBCD, 
 
aluminium trihydrate, magnesium hydroxide and phosphate 
esters.144,145 Currently, because of their high performance 
 
eﬃciency and low cost, the largest group of FRs are the brominated 
FRs. Typical conventional polymers using phenolic compounds as 
monomers are phenol formaldehyde-resins. These polymers are 
widely used in various fields, such as wood composites, fiber 
bonding, laminates, foundry resins, abrasives, friction and molding 
materials, coatings and adhesives, and flame retardants. 
Environmental concerns over the potential 
 
risks that halogenated chemicals pose have been around for decades. 
These are rooted in the persistence, bioaccumulation and toxicity 
(PBT) associated with specific brominated organic compounds.145 
To respond to this, the FR research community and others began 
developing non-halogenated flame retardants. 
 
The great synthetic flexibility of organosilicon polymers, viz. 
their ease of processing, low cost, and non-toxic nature, presents an 
attractive alternative solution over current flame retardant 
materials.146 Siloxane-based hybrid polymers that have 
 
organic and inorganic components have been synthesized using 
enzymatic methods under mild and solventless conditions.147–149 
 
A number of aromatic siloxane-based new polyesters and 
polyamides 124a–b were prepared and evaluated for their flame 
retardant properties. In addition, siloxane-based aliphatic polyamides 
125 were also synthesized (Fig. 19). 
 
Flame retardant and thermal properties of the biocatalytically 
generated copolymers 124a–b and 125a–c were studied at their onset 
decomposition temperatures. The copolymers 124a and 124b were 
found to start losing weight around 400 1C, while this temperature 
drops to around 290 1C for the copolymers 125a, 125b and 125c. 
Thus, copolymers 124a and 124b are relatively heat-resistant and can 
be used up to fairly high temperatures. It was observed that the 
copolymers 124a and 124b exhibit flammability similar to Kevlar or 
poly(ether etherketone) (PEEK), the two commercial products of 
Dupont. For applications requiring ultra-fire-safe polymers, it is 
preferable to use polymers whose heat-release capacity is 100 J g 1 K 
1
 and under, such as polyamides 
125b and 125c. 
 
Furthermore, nanoclay was used as a potential additive in the 
above siloxane copolymers, which was then blended with polyolefin 
materials to improve their thermal as well as flame retardant 
properties. Moreover, the addition of siloxane co-polymer 126 (Fig. 
20) in polypropylene improved the thermal stability of 
polypropylene by 60 1C, whereas the improvement in thermal 
stability of polypropylene went up by 73 1C when polypropylene 
was blended with nanoclay mixed siloxane co-polymer 126. Thus, 
on the basis of decomposition tempera-tures, polypropylene blended 
with a mixture of nanoclay and siloxane co-polymer 126 was found 
to be relatively more heat-resistant and can therefore be used at fairly 
high temperatures. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 19 Silicone-based aromatic/aliphatic polyamides and polyesters. 
 
 
 
  
 
 
 
 
 
 
 
 
Fig. 20 Silicone-based 5-aminoisophthalate polyamides. 
 
 
 
The mixtures of nanoclay and siloxane co-polymer 126 showed a 
better performance in terms of heat release capacity as compared to 
siloxane co-polymer 126 alone in polypropylene, and a decrease of 
68 J g 1 K 1 in heat release capacity was observed from 
polypropylene to polypropylene blended with nanoclay and the 
siloxane co-polymer 126.148,149 
 
To enhance the eﬃcacy of the biocatalytically synthesized 
copolymers 124–126, their nanocomposites containing titanium 
dioxide (TiO2) were prepared, and TiO2 nanoparticles were also 
prepared for comparison. The thermal and flame-retardant properties 
of these materials were investigated. Thermogravi-metric analysis 
(TGA) studies were carried out on various TiO2–polymer 
compositions to investigate the effect of TiO2 nanoparticles on the 
decomposition temperature of these novel polymers. The 
decomposition temperature of polymer 127a 
 
is increased from 408 1C to 425 1C by adding 20 wt% of nc-TiO2 
(Fig. 21).150 
 
Another study shows how the use of chemoselective enzymatic 
synthesis of polydimethylsiloxanes, based upon a 5-aminoiso-
phthalate moiety, increases the aromatic stabilizing groups in 
polydimethylsiloxane and also creates functionality available for 
cross linking (Scheme 29). 
 
Hexamethylene tetramine (HMTA) is a common phenolic cross 
linker, its cross linking capacity and ability decreases the 
flammability of the polymer by removing the branched siloxane 
pathway to degradation, giving rise to only the more stable cyclic 
siloxane structures.151 The copolymer 128, crosslinked with various 
concentrations of hexamethylenetetramine (HMTA), gave the 
crosslinked polymeric system 129, and the heat release capacity 
decreased with the increase in wt% of HMTA. In the crosslinked 
copolymer 129 with 20 wt% of HMTA, the HR capacity drops to 90 
J g 1 K 1, which is very promising and an improve-ment over the 
commercially available Dupont’s flame-retardant polymers, Kevlar 
(292 J g 1 K 1) and PEEK (180 J g 1 K 1). However, the char yields 
and total heat release remained practi-cally similar in all the HMTA 
and copolymer 129 compositions.151 
 
Enzymatic copolymerization of polydimethylsiloxanes carry-ing 
amino end groups with diesters of C-4-methylcoumarins, 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 29 Synthesis of novel crosslinked polydimethyl siloxanes. 
 
 
using the lipase, Candida antarctica, as a biocatalyst, has been 
carried out to yield novel polymers 130 that have C-4-methyl-
coumarin moieties in the backbone.152,153 In a separate synthesis, C-
4-methylcoumarin was also incorporated as a pendant moiety into 
the poly siloxaneisophthalate copolymers 131 by function- 
 
alization of the hydroxyl groups in the isophthalate moiety (Fig. 
22).152,153 
 
Recently, another novel approach of cross linking of 
enzymatically synthesized polydimethyl siloxane copolymers 132 
with aromatic dianhydrides was also reported by us (Scheme 
30).152–154 The resultant cross linked siloxane copolymer 133, could 
easily be coated (in solution form) onto any substrate including 
fabrics and cross linked on the surface by heat treat-ment. This work 
has provided rigid, aromatic and thermally stable cross linkers for 
further improvement of the flame retardant properties of the 
materials in comparison to siloxane copolyamides 
 
 
 
 
 
 
 
 
 
Fig. 21 Enzymatically synthesized siloxane copolyamides. Fig. 22 Coumarin-based silioxane polymers. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 30 Synthesis of polydimethyl siloxane copolymers with aromatic 
dianhydrides. 
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when they were cross linked using hexamethylenetetramine 
(HMTA) as the cross linking agent.152–154 
 
As discussed earlier, the condensation co-polymerization of non-
proteinogenic amino acid derivatives with polyethylene glycol 
(PEG) was developed (Scheme 15) for a controlled release system in 
which the drug is physically adsorbed or entrapped within the 
polymeric matrix. We have investigated the flame retardant 
properties of the hybrid copolymers 134, formed by the bio-catalytic 
acylation of non-proteinogenic amino acid diesters by amino 
terminated polysiloxanes of varying molecular weights (600 and 
900) in bulk (siloxane acting as solvent also) (Scheme 31). The 
degree of polymerization was extremely dependent on the nature 
(hydrophilic/hydrophobic) of the macromer and the length of the 
alkyl chain in the malonate derivatives as well as on the 
nucleophilicity of the reactive functional group of the macromer.155 
 
The first biocatalytic synthesis of siloxane copolyimides, 
siloximide E (135), using aminopropyl-terminated polydimethyl-
siloxane and 4,40-oxydiphthalic anhydride in the presence of 
 
 
 
 
 
Scheme 32 Siloxane-based polyimides. 
 
 
lipase as the biocatalyst without using any solvent was performed by 
us (Scheme 32).156 
 
To confirm the role and establish the importance of using lipase 
as a catalyst in these reactions to drive the reaction to imide 
formation, the biocatalytically synthesized polyimide was com-pared 
with the same polyimide synthesized without using a biocatalyst. It 
is known in the literature that polyimide preparation using traditional 
chemical methods (without a biocatalyst) involve the initial 
formation of polyamic acid, followed by ring closure to form the 
polyimide. It is interesting to note that in our enzymatic synthesis, 
the cyclization takes place in situ and gives rise to a clean linear 
polyimide product without the formation of polyamic acid, thus 
avoiding the need for any further processing and purification. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 31 Biocatalytic acylation of diethyl malonate derivatives with 
diaminosiloxanes. 
 
11. Unconventional media for lipase 
catalysis 
 
11.1 Microwave-assisted lipase catalyzed synthesis 
 
Microwave-assisted synthesis is well-known in organic and 
 
radiochemistry for milder reaction conditions, enhanced rates of 
reactions and a reduction in overall reaction times.157–163 
 
However, its applications in enzyme catalyzed reactions are fairly 
new. This section vignettes a few examples of microwave-assisted 
heating in lipase catalyzed reactions and their impact on reaction 
time, reaction conditions, product yield, chemo-, regio- and 
enantioselectivity in comparison to conventional heating.164–167 
Ribeiro et al. attempted a lipase (CAL B) catalyzed enantioselective 
acetylation of ( )2,2,2-trifluoro-1-phenylethanol 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 33 Comparison of CAL B catalyzed acetylation under micro-wave 
and convention heating. 
 
 
(136) with vinyl acetate under conventional heating using an oil bath 
and microwave heating (Scheme 33).163 Interestingly, under 
microwave irradiation the racemic mixture was resolved to 100% of 
the R-isoform of 2,2,2-trifluoro-1-phenylethanol (136a) but no 
acetylation was observed.165 Whereas, under conventional oil bath 
heating, 3% of the (S)-isoform of the acetylated analog 137a was 
observed along with 97% of the R-isoform of 2,2,2-trifluoro-1-
phenylethanol in 2 h (136a). 
 
In another study, Ziaullah et al. investigated the eﬀ ect of 
microwave heating on CAL B catalyzed esterification of quercetin-
3-O-glucoside and phloretin-20-glucoside with a variety of long 
chain fatty acids (Scheme 34) in comparison to conventional 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 34 CAL B catalyzed esterification of quercetin-3-O-glucoside and 
phloretin-20-glucoside under convention and microwave heating. 
 
heating under similar molar ratios of reactants and enzyme.164 In 
conventional heating, lipase catalyzed esterification of 138 and 140 
to 139 and 141, respectively, were achieved between 18–24 h with 
81–98% yield.164 Whereas, when the same reac-tions were carried 
out under microwave heating, esterified products were obtained only 
in 120–160 seconds with a similar molar quantity of the reactants 
and enzyme in slightly better yields. Moreover, when the authors 
carried out the same esterification reactions under solvent-free 
conditions under microwave heating, the reaction time was even 
further reduced to 75–105 seconds with 85–98% yields.164 The 
present study evidently demonstrates faster lipase catalyzed 
esterification under microwave heating with a drastic reduction in 
the overall reaction time compared to conventional heating. 
 
 
11.2 Ultrasound-assisted lipase catalyzed synthesis 
 
Similar to microwave-assisted lipase catalyzed synthesis, studies 
 
have been done to evaluate the eﬀ ect of ultrasound on lipase 
catalyzed esterification reactions.166–169 Zheng et al. have inves- 
 
tigated lipase catalyzed esterification of naringin (142), a well-
known flavonoid with various unsaturated fatty acids after 
ultrasound pretreatment to 143 (Scheme 35).168 In this study, the 
authors have reported that an ultrasound pretreatment of the reaction 
mixture has accelerated the rate of reaction and reduced the overall 
reaction time from 96 h to 72 h with a considerable enhancement in 
ester 143 yield in comparison to ultrasound untreated reaction.168 
 
11.3 Lipase catalyzed reactions in ionic liquids 
 
In another study, Wang et al. observed an increase in the rate of the 
reaction when lipase-catalyzed synthesis of methyl caﬀ eate (144) 
was carried out under ultrasound irradiation in an ionic liquid.169 In 
this study, the lipase catalyzed esterification of caﬀ eic acid with 
methanol using 25 kHz ultrasound frequency at 150 W power in a 
[Bmim][Tf2N] ionic liquid at 75 1C was carried out. The reaction 
was competed in 9 h with a 99.79% yield of methyl caﬀ eate.169 
However, in a conventional incuba-tor shaker, the same reaction was 
completed in 36 h with a 96.54% yield. This study clearly 
demonstrates enhancement in the rate of reaction and a 4-fold 
reduction in reaction time 
 
with a somewhat increase in the yield of methyl caﬀ eate (144) 
(Scheme 36).169 
 
11.4 Lipase and ruthenium catalyzed dynamic kinetic 
resolution of secondary alcohols 
 
Kinetic resolution is the diﬀ erentiation of two enantiomers from a 
racemic mixture and is based on the diﬀ erence in the 
 
rates of reaction of an individual enantiomer over the other with a 
chiral catalyst or reagent.170–175 During this process, one 
 
of the two enantiomers remains unreactive and as a result a 
maximum of 50% of the theoretical yield can be achieved.173,174 
 
However, this limitation can be addressed by one of the follow-ing: 
(i) use of a prochiral substrate,170 (ii) strereoinversion of the left-
over enantiomer,171 or (iii) dynamic kinetic resolution.172–175 In the 
case of dynamic kinetic resolution, the substrate continuously 
undergoes isomerization/racemization by virtue of another catalyst 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 35 CAL B catalyzed esterification of naringin under ultrasound pretreatment. 
 
 
 
 
 
 
Scheme 36 CAL B catalyzed synthesis of methyl caﬀeate in an ionic liquid 
under ultrasound irradiation. 
 
 
even during the process of kinetic resolution with a chiral catalyst 
and thus all the racemic mixture can be utilized and even up to 100% 
theoretical yield can be achieved. 
 
Persson et al. applied a combination of ruthenium metal complex 
[Ru2(CO)4(m-H)(C4Ph4COHOCC4Ph4)] for substrate racemization 
and Candida antarctica lipase for enantioselective acylation (Scheme 
37) in the same reaction for an eﬃcient and high yield kinetic 
resolution.173 In this study, the authors investigated two diﬀ erent 
ruthenium complexes ([Ru2(CO)4(m-H)-(C4Ph4COHOCC4Ph4)]) 
and [(PPh3)3RuCl2] for the dynamic race-mization of 1-phenyl 
ethanol and various acyl donors for enantioselective acylation using 
lipase to (R)-1-phenylethyl acetate (145). It is noted that 4-
chlorophenyl acetate was the most suitable acyl donor among other 
studied acyl donors for the enantioselective acylation of 1-phenyl 
ethanol in the presence of ruthenium and lipase catalysts. In this 
study the authors 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 37 Ruthenium and lipase catalyzed dynamic kinetic resolution and 
enantioselective acetylation of a secondary alcohol. 
 
apparently showed that 100% of the racemic mixture can be 
transformed to an enantioselective product. 
 
In another study, Persson et al. investigated the same combination 
of lipase and ruthenium complex for the dynamic kinetic resolution 
and acylation of secondary symmetrical diols.174 A representative 
example of this study is depicted in Scheme 37B, where (dl/meso B 
50/50) 2,5-hexanediol was treated with a ruthenium catalyst, 
Candida antarctica lipase, and with 4-chlorophenyl acetate as the 
acyl donor in toluene at 70 1C. The obtained product contains 86% 
of (R,R)-2,5-diacetoxy-hexane (146a) and 14% of (meso)-2,5-
diacetoxyhexane (146b). Later Huerta et al. also applied this 
methodology on a-hydroxy esters for dynamic kinetic resolution and 
trans-esterification using the ruthenium catalyst and Pseudomonas 
cepacia lipase to obtain an enantioselective product in a decent 
yield.175 
 
 
12. Conclusions and future outlook 
 
From the foregoing reports, it is clear that biocatalysis using lipases 
is a major contributor to current research and develop-ment activities 
to benefit a wide range of application areas. Biocatalysts, especially 
lipases, certainly bring a new dimension to the organic reactions and 
processes, and demonstrate ‘‘Green Chemistry’’ pathways involving 
fewer by-products and less (or no) toxic chemicals or reagents. This 
is highly useful for biomedical research where the purity of the 
material is of utmost importance. The amphiphilic polymers 
developed using the lipase mediated biocatalytic approach are 
biocompatible, non-immunogenic and have the required size for the 
glomerular filtration (renal clearance), which make them suitable 
potential candidates for drug delivery applications. The PEGylated 
com-pounds synthesized through the lipase assisted reactions 
discussed in this article hold great potential in maneuvering the 
creation and development of new materials that have a wide range of 
applica-tions in the healthcare and industrial sectors. A significant 
number of marketed pharmaceuticals contain active pharmaceutical 
ingredients that are manufactured in part using biocatalysis as a key 
enabling technology. Though the utilization of biocatalysis is 
growing due to significant advances in technologies for enzyme 
discovery, supply, and improvement, as well as an increased focus 
on applications for chiral drugs, drug delivery systems and green 
chemistry, there still remains a lack of clarity around the quality and 
regulatory expectations when using biotransformations in research 
and manufacturing, and this 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
lack of clarity can be a barrier to the uptake and adoption of 
biocatalysis (Wells et al., Org. Proc. Res. Dev., 2012, 16, 1986). 
Thus a rational, coherent and achievable strategy for the use of 
biocatalysis in the manufacture of small molecule active 
pharmaceutical ingredients (APIs) or drug delivery systems based on 
a scientific, risk-based approach to drug quality and patient safety is 
needed. Currently, there is no specific guidance for handling 
biocatalyst residues in the literature and enzyme residues should be 
treated as potential impurities in the final products. Essentially risk-
based scientific arguments must be used to ensure the quality of the 
API and ultimately the patient. Commonly used drugs, like 
Atorvastatin (Lipitor), Sitagliptin (Januvia) and Pregabalin (Lyrica), 
are manufactured using biocatalysis during the GMP stage of their 
synthesis and the issue of enzyme residue is still under discussion 
(Wells et al., Org. Proc. Res. Dev., 2012, 16, 1986). In spite of the 
eﬀ orts discussed herein to exploit lipases for various applications, a 
great deal of work is still necessary to achieve the goals of ‘‘Green 
and Sustainable Chemistry’’ which are being faced by the scientific 
community, both in academia and industry. 
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